Predictive value of plasma asymmetric dimethylarginine, homocysteine, and high-sensitive CRP levels in occult coronary artery disease: A multidetector-row computed tomography study;Prädiktiver Wert der Plasmawerte für asymmetrisches Dimethylarginin, Homozystein und hochsensitives CRP bei maskierter koronarer Herzkrankheit: Eine Multidetektor-Computertomographie-Studie

Herz

Volumn 40, Issue 3, 2015, Pages 495-501

  Gurel E ^a   Tigen, K ^b   Karaahmet, T ^c   Gecmen C ^d   Mutlu, B ^b   Basaran Y ^b  

^a Ordu State Hospital   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c ACIBADEM UNIVERSITY   (Turkey)

^d KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Asymmetric dimethylarginine; Atherosclerosis; Computed tomography; Coronary artery disease; Risk factors

Indexed keywords

ARGININE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; N,N-DIMETHYLARGININE;

ANALOGS AND DERIVATIVES; BLOOD; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROCEDURES; PROGNOSIS; RADIOGRAPHY; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ARGININE; BIOMARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84890353661     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-013-4022-9     Document Type: Article

References (35)

1. Stamler J, Wentworth D, Neaton JD 9 (1986) Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256(20):2823–2828
2. Pearson TA (2002) New tools for coronary risk assessment. What are their advantages and limitations? Circulation 105:886–892
3. Vallance P, Leone A, Calver A et al (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572–575
4. Lu TM, Ding YA, Lin SJ et al (2003) Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J 24:1912–1919
5. Meinitzer A, Seelhorst U, Wellnitz B et al (2007) Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 53:273–283
6. Ridker P (2001) High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818
7. The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015–2022
8. Degertekin M, Gemici G, Kaya Z et al (2008) Safety and efficacy of patient preparation with intravenous esmolol before 64-slice computed tomography coronary angiography. Coron Artery Dis 19:33–36
9. HoffmannMH, Shi H, Schmitz BL et al (2005) Noninvasive coronary angiography withmultislice computed tomography. JAMA 293:2471–2478
10. Leber AW, Knez A, Becker A et al (2004) Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J Am Coll Cardiol 43:1241–1247
11. Achenbach S, Moselewski F, Ropers D et al (2004) Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 109:14–17
12. Böger RH (2003) Association of asymmetric dimethylarginine and endothelial dysfunction. Clin Chem Lab Med 41:1467–1472
13. Valkonen VP, Paiva H, Salonen JT et al (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358(9299):2127–2128
14. Nijveldt RJ, Teerlink T, Van Der HovenB et al (2003) Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 22(1):23–33
15. Schnabel R, Blankenberg S, Lubos E et al (2005) Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97(5):e53–e59
16. Evans RW, Shaten BJ, Hempel JD et al (1997) Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 17:1947–1953
17. Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77:1370–1376
18. Al-Obaidi MK, Philippou H, Stubbs PJ et al (2000) Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation 101:372–377
19. Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397
20. Koenig W, Sund M, Frohlich M et al (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study 1984–1992 Circulation 99:237–242
21. Fichtlscherer S, Rosenberger G, Walter DH et al (2000) Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102(9):1000–1006
22. Hunt ME, O’Malley PG, Vernalis MN et al (2001) C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 141(2):206–210
23. Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14):1387–1397
24. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E et al (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375(9709):132–140
25. Korosoglou G, Lehrke S, Mueller D et al (2011) Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque. Heart 97(10):823–831
26. Laufer EM, Mingels AM, Winkens MH et al (2010) The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol 30(6):1269–1275
27. Emond M, Mock MB, Davis KB et al (1994) Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 90:2645–2657
28. Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 27:1341–1381
29. Farb A, Burke AP, Tang AL et al (1996) Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 93:1354–1363
30. Yokoya K, Takatsu H, Suzuki T et al (1999) Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year. Circulation 100:903–909
31. Nissen SE, Tuzcu EM, Schoenhagen P et al (2005) Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352:29–38
32. Butler J, Shapiro M, Reiber J et al (2007) Extent and distribution of coronary artery disease: a comparative study of invasive versus noninvasive angiography with computed angiography. Am Heart J 153:378–384
33. Voros S, Rinehart S, Qian Z et al (2011) Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging 4(5):537–548
34. Boogers MJ, Broersen A, Velzen JE van et al (2012) Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J 33(8):1007–1016
35. Versteylen MO, Kietselaer BL, Dagnelie PC et al (2013) Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome. J Am Coll Cardiol 61(22):2296–2305